Abstract
The generic pharmaceuticals sector has been expanding strongly in recent years
as the need for cheaper medicines worldwide has increased. The next five years
from 2009 will see more leading drugs going off patent, thus increasing
opportunities for generics producers. Regulations favouring generic products
give cause for optimism in the generics sector, while still leaving scope for
novel branded drugs. We predict that total revenues in the generics market
will continue to increase in the years ahead.
Major players have been moving into the generic drugs market - spearheaded by
leading pharma companies and specialist pharma organisations. Established
generics companies, such as Teva, are increasing in commercial prominence and
international reach. There are many rising challengers in developed and
developing countries, inspired by patent expiry on major drugs. What will be
the main challenges and the main opportunities in this market from 2009
onwards? Our new report, World Generics Market 2009-2024, investigates such
questions in depth, providing you with the information that you need.
This report reveals forecasted sales in the world generics market and in
leading national markets, providing detailed quantitative and qualitative
data. In particular, World Generics Market 2009-2024 includes generics market
forecasts for:
- The US
- Europe (with special focus on Germany, France, the UK, Italy and Spain)
- Japan
- China
- India
- Russia.
Our report also gives in-depth profiles of the five leading generic
manufacturers: Teva, Sandoz, Mylan, Watson and Ratiopharm.
Comprehensive analysis of the global generics sector
World Generics Market 2009-2024 examines that sector critically, through a
comprehensive review of information sources. This report provides detailed
sales forecasts, discussions of developments and analyses of commercial
drivers and restraints, including a SWOT analysis. There are 61 tables and
figures and a full interview with an expert in the sector. The result is a
comprehensive market- and industry-centred report, with detailed analyses and
informed opinion to benefit your work.
Why you should buy World Generics Market 2009-2024
In this report you will receive the following benefits in particular:
- You will receive an appraisal of the current world generics market
- You will receive analyses of the potential value of the world generics
market, including detailed revenue forecasts from 2009 to 2024
- You will receive analyses of the most-promising areas for generic drug
development and marketing
- You will receive forecasts for principal geographical markets, especially
those with high growth potential
- You will examine strengths and weaknesses of the worldwide generics sector
from 2009 onwards, especially commercial drivers and restraints
- You will discover expert opinion from our industry survey.
| 
View Cart
